Recombinant Human SARS-CoV-2 Spike Glycoprotein S1 RBD (HEK)715-H16-0BU- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human SARS-CoV-2 Nucleoprotein (HEK)715-H17-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human Angiotensin-converting enzyme 2 (ACE2) Extracellular Domain 19-615 (HEK)715-H19-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human SARS-CoV-2 Spike RBD, Variant 501Y.V1, Lineage B.1.1.7, UK (HEK)715-H20-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human SARS-CoV-2 Spike RBD, Variant 501Y.V2, Lineage B.1.351, South Africa (HEK)715-H21-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human SARS-CoV-2 Spike RBD, Variant 501Y.V3 Lineage B.1.1.248, Brazil & Japan (HEK)715-H22-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human SARS-CoV-2 Spike RBD, Variant Lineage B.1.617, India (HEK)715-H24-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2
- Recombinant Human SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2 (HEK)715-H25-0BU
- Recombinant Protein
- Antigens > Infectious Diseases > SARS-CoV-2